Feb72018 Anavex Life Sciences Provides Clinical Programs Update and Reports Fiscal First Quarter 2018 Financial Results February 7, 2018
Feb52018 Anavex Life Sciences to Announce Fiscal First Quarter 2018 Financial Results and Provide an Update on Clinical Programs and Corporate Highlights on Wednesday, February 7, 2018 February 5, 2018
Jan242018 Anavex Life Sciences to Present at the Noble Capital Markets 14th Annual Institutional Investor Conference January 24, 2018
Jan162018 Anavex Life Sciences Reports Potential Normalization of Hypertension with ANAVEX®2-73 Published in The Journal of Clinical Hypertension January 16, 2018
Jan82018 36th Annual J.P. Morgan Healthcare Conference in San Francisco on Jan. 8th-11th January 8, 2018
Dec112017 Anavex Life Sciences Reports Fiscal 2017 Financial Results And Provides Update On Therapeutic Programs December 11, 2017
Nov212017 Anavex Life Sciences Reports Newly Published Data on Alzheimer’s Disease Research Demonstrate the Neuroprotective Features of the Sigma-1 Receptor November 21, 2017
Nov82017 Anavex Life Sciences to Present at the 5th Annual Mental Health Parity Addiction Equity Act Business Roundtable in Washington, DC November 8, 2017
5th Annual Mental health Parity Addiction Equity Act Business Roundtable in Washington DC on November 8, 2017 November 6, 2017
Anavex® Life Sciences presenting at Society for Neuroscience Nov. 11-15, 2017 in Washington DC November 6, 2017
Nov42017 Anavex Life Sciences Presents New Clinical Data of Investigational Alzheimer’s Disease Treatment ANAVEX®2- 73 at 2017 Clinical Trials on Alzheimer’s Disease Meeting November 4, 2017
